Company Filing History:
Years Active: 2014
Title: Fréderic Jeannot: Innovator in Pharmaceutical Chemistry
Introduction
Fréderic Jeannot is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases.
Latest Patents
Fréderic Jeannot holds a patent for "Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives." This invention relates to 6-substituted isoquinoline and isoquinolinone derivatives that are useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase. The patent highlights the potential of these compounds in therapeutic applications.
Career Highlights
Fréderic Jeannot is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi focuses on innovative solutions in drug development, contributing to advancements in medical treatments.
Collaborations
He has collaborated with notable colleagues, including Oliver Plettenburg and Katrin Lorenz, enhancing the research and development efforts within his team.
Conclusion
Fréderic Jeannot's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the treatment of diseases, showcasing the importance of innovation in healthcare.